Real-World Treatment Patterns of Lung Cancer in a Resource-Restricted Country: the Experience of Georgia.

Lung cancer (LC) is the most common malignancy responsible for 1.8 million of deaths worldwide. Lung and bronchus cancer represents 13% (n = 1217) of all new cancer cases in Georgia. In 2018, in Georgian males lung cancer age-standardized incidence rate was 35.7/per 100 000, less compared to regiona...

Descripción completa

Detalles Bibliográficos
Publicado en:Health Services Insights Vol. 14; pp. 1 - 8
Autores principales: Kiladze, Ivane, Mariamidze, Elene, Jeremic, Branislav
Formato: research tables/charts Journal Article
Publicado: Sage Publications Inc. 1/1/2021
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=154321383&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 154321383
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        11786329
        B10H
      jtl: Health Services Insights
      issn: 11786329
      maglogo: Y
    pubinfo:
      dt: 1/1/2021
      vid: 14
      pid: 344
      pub: Sage Publications Inc.
      place: Thousand Oaks, California
    artinfo:
      ui:
        154321383
        154321383
        154321383
        10.1177/11786329211055296
        154321383
      ppf: 1
      ppct: 7
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Real-World Treatment Patterns of Lung Cancer in a Resource-Restricted Country: the Experience of Georgia.
      aug:
        au:
          Kiladze, Ivane
          Mariamidze, Elene
          Jeremic, Branislav
        affil: Department of Clinical Oncology, Caucasus Medical Centre, Tbilisi, Georgia
      sug:
        subj:
          Lung Neoplasms Epidemiology
          Lung Neoplasms Radiotherapy
          Human
          Georgia
          Female
          Male
          Questionnaires
          Surveys
          Prevalence
          Decision Making
          Antineoplastic Agents, Combined
          Carcinoma, Non-Small-Cell Lung Radiotherapy
          Thoracic Surgery, Video-Assisted
          Radiotherapy
          Neoplasm Staging
          Descriptive Statistics
          Female
          Male
      ab: Lung cancer (LC) is the most common malignancy responsible for 1.8 million of deaths worldwide. Lung and bronchus cancer represents 13% (n = 1217) of all new cancer cases in Georgia. In 2018, in Georgian males lung cancer age-standardized incidence rate was 35.7/per 100 000, less compared to regional countries as Turkey (70.6), Russia (48.2), Ukraine (41.7), and Armenia (58.5), but higher than in neighbor Azerbaijan (25.5). Incidence is higher compared to central and eastern Europe (27.3) and near similar to North America (34.5). Georgia is an Eastern European, middleincome country with 3.7 million residents and one of the highest numbers of active smokers in the European Region. The Georgian health care system is divided into a public and a private sector, with coverage of nearly 100% of the population. There is a national healthcare system as well as private insurance and all patients, irrespective of insurance (private or governmental) can choose the hospital for treatment by themselves all over the country. The Basic Package of the Universal Health Care Program includes the treatment of oncologic patients, specifically surgery, chemotherapy, hormone therapy and radiotherapy and investigations and medications related to these procedures. The program covers all types of laboratory and instrumental investigations related to planned treatment. Georgia lacks an LC screening program for smokers and partially because of this, the majority of patients with lung cancer present at an advanced stage. The National Centre for the Disease Control (NCDC) showed that almost 90% of LC patients in the country present with advanced stages (III-IV) with 60% of patients having stage IV disease at diagnosis. Lung cancer is generally diagnosed at an advanced stage. For non-small cell lung cancer (NSCLC), the proportion with metastatic disease (TNM stage IV) ranged from 46.8% to 61.2% in developed countries. In recent years, there have been several publications addressing specifics of LC worldwide, but none concerning Georgia. In light of the rapidly changing landscape in the diagnosis, staging, and treatment of LC, we thought to define the state of practice in Georgia by convening specialists who treat LC across 13 institutions in our country with the goal to describe differences in access and approaches to LC.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N